Pneumococcal Infection
📧 Sign up to get email alerts when something new happens for Pneumococcal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China [Phase 3]
A Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine (13vPnC) in healthy infants in China has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Clinical Trial of PCV24 in Adults Aged ≥18 Years [Phase 1, Phase 2]
This document reports the completion of Phase 1/2 clinical trials of the PCV24 pneumococcal vaccine in adults aged 18 years and older.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) [Phase 1]
This document notes a Phase 1 clinical trial (V118C-002) evaluating a novel pneumococcal vaccine (V118C) in children, with recruitment curre…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses [Phase 4]
Phase 4 clinical trial investigating how neutrophils contribute to the age-related decline in anti-pneumococcal vaccine responses; currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age [Phase 3]
Phase 3 lot-to-lot consistency study evaluating a 21-valent pneumococcal conjugate vaccine in healthy infants starting at 2 months of age. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) [Phase 3]
Phase 3 trial of the V116 vaccine for pneumococcal infection in children and teenagers has been completed, with results posted.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Clinical Trial of PCV24 in Infants Aged 2-23 Months [Phase 1]
A Phase 1 clinical trial to evaluate the safety and immunogenicity of PCV24 in infants aged 2-23 months is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years [Phase 2]
A Phase 2 clinical trial of the 24-valent pneumococcal conjugate vaccine PCV24 in infants and children aged 2 months to 5 years is currently…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Opportunistic Pneumococcal Immunisation Trial in MALnutrition [Phase 4]
Phase 4 clinical trial to assess opportunistic pneumococcal immunisation in children with severe acute malnutrition. The trial status is NOT…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization
Completed clinical trial evaluating the impact of a pharmacist-led intervention on vaccination status for patients at risk of pneumococcal i…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk. [NA]
A completed clinical trial evaluating a collaborative medico-pharmaceutical care approach to improve vaccination coverage to prevent pneumoc…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants [Phase 2]
GlaxoSmithKline completed a Phase 2 trial evaluating the safety, tolerability, and immune response of the AFX3772 vaccine in healthy infants…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV
Pfizer-sponsored clinical trial evaluating the effects of a pneumococcal vaccine in people with HIV has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
A completed clinical trial assessing the safety of the 23-valent pneumococcal polysaccharide vaccine in the target population. Sponsor: Sino…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma [Phase 4]
Phase 4 trial assessing immunogenicity of a pneumococcal vaccination strategy in adults treated for Non-Hodgkin lymphoma, comparing PCV13+PP…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008) [Phase 3]
Phase 3 trial update reporting safety and immunogenicity results for the V116 pneumococcal vaccine in adults at increased risk for pneumococ…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants [Phase 4]
Phase 4 trial in Kenyan infants assessing whether fractional dosing of pneumococcal conjugate vaccines preserves immunogenicity and reduces …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older [Phase 1]
Phase I clinical trial of PCV24 in adults aged 18 and older has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. [Phase 2]
Phase 2 clinical trial update for a pneumococcal conjugate vaccine tested in adults aged 50 to 84; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of V116 in pneumococcal vaccine-naïve adults has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911) [Phase 3]
Phase 3 study results assess safety, tolerability, and immunogenicity of co-administering V110 or V114 with a booster dose of mRNA-1273 in h…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002) [Phase 1]
Phase 1 trial update on safety, tolerability, and immunogenicity of the polyvalent pneumococcal conjugate vaccine V116 in Japanese adults; r…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents [Phase 4]
Phase 4 clinical trial evaluating pneumococcal vaccination in multiple myeloma patients receiving novel therapies has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old [Phase 4]
A Phase 4 trial evaluating safety and immunogenicity of revaccination with PPV23 in adults aged 60-70 years has completed.